Institutions Risk Assessment Program Turns 30: Fox Chase Program Helps People Understand Genetic Risks for Cancer October 25, 2021
TCL Archive Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC December 19, 2014